Home › NDC Lookup › RxCUI directory › RxCUI 2045959

{10 (avatrombopag 20 MG Oral Tablet [Doptelet]) } Pack [Doptelet 40 MG Daily Dose Carton] — RxCUI 2045959

RxNorm drug concept · Brand name pack
RxCUI 2045959 Brand name pack · BPCK ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2045959
Official name{10 (avatrombopag 20 MG Oral Tablet [Doptelet]) } Pack [Doptelet 40 MG Daily Dose Carton]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asDoptelet 40 MG Daily Dose Carton Pack
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)2,342 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Avatrombopag: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It raises low platelet counts. You may be taking it before a procedure if you have chronic liver disease, or long term if you have immune thrombocytopenia (ITP) that hasn't respond...
  • Take it by mouth once a day with food, just as prescribed. If you're using Doptelet Sprinkle, open the capsule, mix the granules into a soft food or liquid, and take or give it rig...
  • Platelet counts begin to rise in about 3 to 5 days and peak around 10 to 13 days. That's why, for a procedure, you start about 10 to 13 days ahead. With ITP, regular blood tests gu...
  • Headache and tiredness are common. Some people also get fever, nausea, belly pain, swelling, bruising, nosebleeds, or cold-like symptoms. Tell me if any of these bother you or get...
📖 Read our full Avatrombopag guide →

🕸️ Concept Web — How {10 (avatrombopag 20 MG Oral Tablet [Doptelet])... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {10 (avatrombopag 20 MG Oral Tablet [Doptelet]) } Pack [Doptelet 40 MG Daily Dose Carton] RxCUI 2045959

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Avatrombopag 2045726
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Doptelet 2045953
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Avatrombopag Oral Tablet 2045950
    • Avatrombopag Oral Product 2045948
    • Avatrombopag Pill 2045949
    • Avatrombopag Oral Tablet [Doptelet] 2045955
    • Doptelet Oral Product 2045956
    • Doptelet Pill 2045957
    • Pack 746839
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Avatrombopag 20 MG Oral Tablet [Doptelet] SBD · 2045958
  • Avatrombopag 20 MG [Doptelet] SBDC · 2045954
  • Avatrombopag Oral Tablet [Doptelet] SBDF · 2045955
  • Doptelet Oral Product SBDG · 2045956
  • Doptelet Pill SBDG · 2045957
  • Doptelet BN · 2045953

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 2045959 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71369-0010-30 1 BOTTLE in 1 CARTON (71369-010-30) / 30 GRANULE in 1 BOTTL... Doptelet Sprinkle AkaRx, Inc. 2025-07-25
71369-0020-10 1 BLISTER PACK in 1 CARTON (71369-020-10) / 10 TABLET, FILM... DOPTELET AkaRx, Inc. 2018-05-23
71369-0020-15 1 BLISTER PACK in 1 CARTON (71369-020-15) / 15 TABLET, FILM... DOPTELET AkaRx, Inc. 2018-05-23
71369-0020-30 2 BLISTER PACK in 1 CARTON (71369-020-30) / 15 TABLET, FILM... DOPTELET AkaRx, Inc. 2019-06-26
Observed labelers: AkaRx, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.